Santhera Pharmaceuticals (0QN1.LSE) Q3 2024 Earnings

Sep 12Confirmed
Q1 2023
Q2 2023
Q2 2024
Q3 2024
-1.28
-0.85
-0.43
0

Details

Expected EPS
N/A
Actual EPS
-1.2764243142
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Santhera Pharmaceuticals⁩ (⁦0QN1.LSE⁩) has reported earnings of ⁦-1.2764243142⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts